Phase II Study of Vincristine Sulfate Liposomes Injection in Patients with Metastatic Uveal Melanoma
Bedikian AY, Sato T, Kim KB, Papadopoulos NE, Hwu W, Homsi J, Davies M, Cheung C, Imperiale SM, Prasad P, Hwu P
Association Between Immune-Related Adverse Events (irAEs) and Disease Control or Overall Survival in Patients with Advanced Melanoma Treated with 10 mg/kg Ipilimumab in Three Phase II Clinical Trials
J Lutzky, J Wolchok, O Hamid, C Lebbe, H Pehamberger, G Linette, V de Pril, R Ibrahim, A Hoos, and S O'Day
Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion
Reintgen DS; Pendas S; Jakub J; Chan H; Nobo C; Puleo C; and Shivers S
Optimizing Regional Melanoma Therapy: Systemic Sorafenib, an Inhibitor of the B-raf Kinase, Augments the Effectiveness of Concurrently Administered Regional Melphalan Chemotherapy in an Animal Model of Advanced Extremity Melanoma
Toshimitsu H; Augustin C; Padussis JC; and Tyler DS
Validation Study of the S-Classification for Melanoma in Positive Sentinel Nodes
Younan RJ, et al.